Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 75 citing articles:

Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
Qingfang Han, Wenjia Li, Kaishun Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 345
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 135
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 123
Engineered extracellular vesicles and their mimetics for cancer immunotherapy
Chunping Liu, Yichao Wang, Longmei Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 679-698
Closed Access | Times Cited: 104
Roles of exosomes in immunotherapy for solid cancers
C. Lyu, Haifeng Sun, Zhenqiang Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 39
The mTORC2 signaling network: targets and cross-talks
Aparna Ragupathi, Christian Kim, Estela Jacinto
Biochemical Journal (2024) Vol. 481, Iss. 2, pp. 45-91
Open Access | Times Cited: 25
Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
Hao Wang, Yi Zhang, Hao Zhang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 21
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Xian Li, Xueqiang Peng, Yan Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCC
Dezhi Li, Jie Qin, Tao Zhou, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 4
Open Access | Times Cited: 27
HMGB1 in the interplay between autophagy and apoptosis in cancer
Ruochan Chen, Zou Ju, Xiao Yan Zhong, et al.
Cancer Letters (2023) Vol. 581, pp. 216494-216494
Closed Access | Times Cited: 27
The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
Chen Xue, Xinyu Gu, Qingmiao Shi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Extracellular vesicles in tumor immunity: mechanisms and novel insights
Liwen Kuang, Lei Wu, Yongsheng Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease
Yuru Zong, Xuliang Wang, Bing Cui, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1562-1576
Open Access | Times Cited: 22
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment
Min Shi, Jun-Su Jia, Guosheng Gao, et al.
Biochemistry and Biophysics Reports (2024) Vol. 38, pp. 101695-101695
Open Access | Times Cited: 6
The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem
Cheng‐Liang Kuo, Ying‐Chen Lin, Yu Kang Lo, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110710-110710
Open Access | Times Cited: 6
Unbalanced Glutamine Partitioning between CD8T Cells and Cancer Cells Accompanied by Immune Cell Dysfunction in Hepatocellular Carcinoma
Jianfei Chen, Rui Wang, Zhongliang Liu, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3924-3924
Open Access | Times Cited: 24
Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling
Yong Xi, Yaxing Shen, Lijie Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 73, pp. 78-92
Closed Access | Times Cited: 16
MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 15
The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
Ruochan Chen, Ju Zou, Rui Kang, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 7-9, pp. 569-590
Closed Access | Times Cited: 14
Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
Tanghua Li, Jiapeng Jiao, Haoteng Ke, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer
Lirong Zhai, Xiao Yang, Yuan Cheng, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 16337-16358
Open Access | Times Cited: 13
Glutamine metabolic reprogramming in hepatocellular carcinoma
Yanyan Ye, Bodong Yu, Hua Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top